Quince Therapeutics (QNCX) said Friday it has changed its name to IRulya Therapeutics, effective later today.
The company said its stock will begin trading on the Nasdaq Capital Market under the "IRLA" ticker on Monday.
The name change follows the completion of Quince's merger with Orphai Therapeutics, the company said.